Global Biologics Market Size & Outlook

The biologics industry worldwide is expected to reach a projected revenue of US$ 1,009.4 million by 2030. A compound annual growth rate of 10.1% is expected of the worldwide biologics industry from 2025 to 2030.

Revenue, 2024 (US$M)
$566.6
Forecast, 2030 (US$M)
$1,009.4
CAGR, 2025 - 2030
10.1%
Report Coverage
Worldwide

Global biologics market highlights

  • The global biologics market generated a revenue of USD 566.6 million in 2024 and is expected to reach USD 1,009.4 million by 2030.
  • The market is expected to grow at a CAGR (2025 - 2030) of 10.1% by 2030.
  • In terms of segment, microbial accounted for a revenue of USD 329.7 million in 2024.
  • Others Biologics Source is the most lucrative biologics source segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2024.
  • Country-wise, Brazil is expected to register the highest CAGR from 2025 to 2030.

Global data book summary

Market revenue in 2024USD 566.6 million
Market revenue in 2030USD 1,009.4 million
Growth rate10.1% (CAGR from 2024 to 2030)
Largest segmentMicrobial
Fastest growing segmentOthers Biologics Source
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationMicrobial, Mammalian, Others Biologics Source

Other key industry trends

  • In terms of revenue, the North America accounted for 44.4% of the global biologics market in 2024.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, Brazil is the fastest growing regional market and is projected to reach USD 13.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biologics Market Scope

Biologics market segmentation & scope
Microbial
Mammalian
Others Biologics Source
Vaccines
Recombinant Proteins
Antisense & RNAi Therapeutics
Others Product
Therapeutic
Diagnostics
Protein Purification
Others MABs by Application
Humanized
Chimeric
Human
Murin
Others MABs by Type
Immunological Disorders
Cardiovascular Disorders
Hematological Disorders
Others Disease Category
Monoclonal antibodies (MABs)
Vaccines
Antisense & RNAi Therapeutics
Recombinant Proteins
Others Oncology
Vaccines
MABs
Antisense & RNAi Therapeutics
Recombinant Proteins
Others Infectious Diseases
In-house
Outsourced

Biologics Market Companies

Name Profile # Employees HQ Website

Global biologics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biologics market will help companies and investors design strategic landscapes.


microbial was the largest segment with a revenue share of 58.19% in 2024. Horizon Databook has segmented the Global biologics market based on microbial, mammalian, others biologics source covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Biologics Biologics Source Outlook (Revenue, USD Million, 2018-2030)
    • Microbial
    • Mammalian
    • Others Biologics Source
  • Global Biologics Biologics Product Outlook (Revenue, USD Million, 2018-2030)
    • Vaccines
    • Recombinant Proteins
    • Antisense & RNAi Therapeutics
    • Others Product
    • Monoclonal Antibodies
      • MABs by Application
        • Therapeutic
        • Diagnostics
        • Protein Purification
        • Others MABs by Application
      • MABs by Type
        • Humanized
        • Chimeric
        • Human
        • Murin
        • Others MABs by Type
  • Global Biologics Disease Category Outlook (Revenue, USD Million, 2018-2030)
    • Immunological Disorders
    • Cardiovascular Disorders
    • Hematological Disorders
    • Others Disease Category
    • Oncology
      • Monoclonal antibodies (MABs)
      • Vaccines
      • Antisense & RNAi Therapeutics
      • Recombinant Proteins
      • Others Oncology
    • Infectious Diseases
      • Vaccines
      • MABs
      • Antisense & RNAi Therapeutics
      • Recombinant Proteins
      • Others Infectious Diseases
  • Global Biologics Manufacturing Outlook (Revenue, USD Million, 2018-2030)
    • In-house
    • Outsourced

Reasons to subscribe to Global biologics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global biologics market databook

  • Our clientele includes a mix of biologics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global biologics market , including forecasts for subscribers. This global databook contains high-level insights into Global biologics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global biologics market statistics, by regions, 2018-2030 (US$M)

Top 10 countries: Biologics market size, 2024 (USD Million)

Top 10 countries: Biologics market size, 2024 (USD Million)

Global biologics market, by region, 2024 (US$M)

Global biologics market statistics, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more